MedPath

江苏神龙药业有限公司

Ownership
-
Established
2001-02-26
Employees
-
Market Cap
-
Website
www.jsslyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

156

NMPA:156

Drug Approvals

Methocarbamol Injection

Product Name
美索巴莫注射液
Approval Number
国药准字H20254366
Approval Date
May 27, 2025
NMPA

Famotidine Injection

Product Name
法莫替丁注射液
Approval Number
国药准字H20253508
Approval Date
Mar 4, 2025
NMPA

Amiodarone Hydrochloride Injection

Product Name
盐酸胺碘酮注射液
Approval Number
国药准字H20243028
Approval Date
Jan 9, 2024
NMPA

Roxithromycin Dispersible Tablets

Product Name
罗红霉素分散片
Approval Number
国药准字H20083796
Approval Date
May 5, 2023
NMPA

Roxithromycin Dispersible Tablets

Product Name
罗红霉素分散片
Approval Number
国药准字H20083795
Approval Date
May 5, 2023
NMPA

Roxithromycin Dispersible Tablets

Product Name
罗红霉素分散片
Approval Number
国药准字H20083794
Approval Date
May 5, 2023
NMPA

Pamidronate Disodium

Product Name
帕米膦酸二钠
Approval Number
国药准字H20065197
Approval Date
Jul 23, 2021
NMPA

Pamidronate Disodium Injection

Product Name
帕米膦酸二钠注射液
Approval Number
国药准字H20065199
Approval Date
Jul 23, 2021
NMPA

Pamidronate Disodium Injection

Product Name
帕米膦酸二钠注射液
Approval Number
国药准字H20065198
Approval Date
Jul 23, 2021
NMPA

Tiopronin Injection

Product Name
维春
Approval Number
国药准字H20050513
Approval Date
Nov 2, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.